iTRAQ-based quantitative proteomics revealing the therapeutic mechanism of a medicinal and edible formula YH0618 in reducing doxorubicin-induced alopecia by targeting keratins and TGF-β/Smad3 pathway
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81904272)
- Guangzhou University of Chinese Medicine
- Shenzhen Technology University (GDRC202123)
This publication has 53 references indexed in Scilit:
- iTRAQ-based quantitative proteomics and network pharmacology revealing hemostatic mechanism mediated by Zingiberis Rhizome Carbonisata in deficiency-cold and Hemorrhagic Syndrome rat modelsChemico-Biological Interactions, 2021
- Association of Inflammation With Progression of Hair Loss in Women With Frontal Fibrosing AlopeciaJAMA Dermatology, 2020
- Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinomaPhytomedicine, 2019
- 046 Progranulin promotes bleomycin-induced skin sclerosis by enhancing TGF-β/Smad3 signaling through up-regulation of TGF-β type I receptorJournal of Investigative Dermatology, 2019
- Chemotherapy-Induced Hair Loss (Alopecia)JAMA Oncology, 2017
- Pathobiology of chemotherapy-induced hair lossThe Lancet Oncology, 2013
- Control of microRNA biogenesis by TGFβ signaling pathway—A novel role of Smads in the nucleusCytokine & Growth Factor Reviews, 2009
- The human keratins: biology and pathologyHistochemistry and Cell Biology, 2008
- Epithelium–mesenchyme compartment interaction and oncosis on chemotherapy-induced hair damageLaboratory Investigation, 2004
- Scalp Cooling therapy and cytotoxic treatmentThe Lancet, 2001